Pulmonary fibrosis inhibited by pentraxin-2/SAP in research study

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry ...

Placenta-derived stem cells may help sufferers of lung diseases

An Italian research team, publishing in the current issue of Cell Transplantation (18:4), has found that stem cells derived from human placenta may ultimately play a role in the treatment of lung diseases, such as pulmonary ...

page 3 from 3